logo

Détails des produits

Created with Pixso. À la maison Created with Pixso. Produits Created with Pixso.
Essai de maladie infectieuse
Created with Pixso.

IRSC-502 -- RSV and SARS-CoV-2 Antigen Combo Rapid Test (Nasopharyngeal Swab)

IRSC-502 -- RSV and SARS-CoV-2 Antigen Combo Rapid Test (Nasopharyngeal Swab)

Nom De Marque: ALLTEST
Numéro De Modèle: IRSC-502
Informations détaillées
Lieu d'origine:
CHINE
Certification:
CE
Précision:
VRS : 96,1 % SRAS-CoV-2 : 98,2 %
Temps de lecture:
15 minutes
Conditions de stockage:
2 à 30°C
Socle:
Disponible
Kit d'essai:
10T
Format:
Cassette
spécimens:
Écouvillon nasopharyngal
Description du produit

The RSV and SARS-CoV-2 Antigen Combo Rapid Test is a rapid chromatographic immunoassay for the qualitative detection of RSV and SARS-CoV-2 infectious diseases in human nasopharyngeal swab specimens as an aid in the diagnostic of RSV and SARS-CoV-2 infectious diseases.

 

RSV (Respiratory Syncytial Virus) and SARS-CoV-2 (the virus that causes COVlD-19) areboth highly contagious respiratory viruses, but they affect populations differently. RSV isa leading cause of severe respiratory illness in infants and older adults, while SARS-CoV-2has caused a global pandemic affecting all age groups. Symptoms of RSV often resemblea common cold but can escalate to bronchiolitis or pneumonia, characterized by severecough, wheezing, and difficulty breathing. In contrast, SARS-CoV-2 infection (COVID-19)presents with a wider range of symptoms, including fever, cough, fatigue, and loss ottaste or smell. While many cases are mild, it can lead to severe pneumonia, acute respira-tory distress syndrome (ARDS), and systemic complications.

 

Product Advantages:
Fast Results in 15 Minutes
High Accuracy
Easy Visual Interpretation
Convenient Procedure

 

Format Cassette Specimen Nasopharyngeal Swab
Certificate CE Reading Time 15 minutes
Storage Temperature 2-30°C Sensitivity RSV: 93.2% SARS-CoV-2: 96.4%
Specificity RSV: 98.1% SARS-CoV-2: 99.0% Accuracy RSV: 96.1% SARS-CoV-2: 98.2%
Pack 10 T